Comparing Retatrutide to Existing Options Understanding how Retatrutide compares to current treatments can help clarify its potential advantages: Semaglutide (Ozempic, Wegovy) Single GLP-1 receptor activation Typical weight loss: 15-20% over 68 weeks Well-established safety profile FDA-approved for weight management Tirzepatide (Mounjaro, Zepbound) Dual GLP-1/GIP receptor activation Typical weight loss: ~20% over 72 weeks Recently FDA-approved Shown to be more effective than semaglutide Retatrutide Triple GLP-1/GIP/Glucagon receptor activation Potential weight loss: Up to 24% in 48-week trials Still in clinical development May offer better energy maintenance during weight loss Current Status and Future Outlook Retatrutide is currently progressing through clinical trials, with Eli Lilly and Company leading the research and development
Discount off of Resting Metabolic Rate testing and V02 max testing GLP-1 4 microdose injections (0.125 mg) $300 4 low dose injections (0.25-1.25 mg) $600 4 high dose injections (1.5-2.4 mg) $800 GLP-2 4 microdose injections 1.25 mg $350 4 low dose injections (2.5-7.5 mg) $700 4 high dose injections (10-15 mg) $900 GLP-3 4 microdose (0.5 mg) $350 4 low dose injections (1-3mg) $700 4 high dose injections (4-6 mg) $900 3 MONTH PROGRAMS get the additional benefits: $200 off low or high dose GLP programs 12 injections with flexible scheduling Free comprehensive bloodwork There are so many benefits to GLPs that go well beyond weight loss
Zepbound uses a dual GIP and GLP-1 pathway
GLP-1 drugs also seem to have anti-addictive properties some users report that they have fewer cravings for alcohol or have become less likely to engage in other addictive behaviors, such as gambling, shopping, or nail-biting
Retatrutide, while showing even greater potential in early studies (up to 24% weight loss), is still in clinical trials and not yet available
The term refers to a group of procedures most commonly gastric sleeve and gastric bypass surgeries that fundamentally alter how the digestive system works
